CLINICAL_TRIALS
trial_result
· 2013-12-04
Clinical Trial Update: Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment [Phase 1]
Summary
Phase 1 study assessing the pharmacokinetics and safety of cabazitaxel in cancer patients with renal impairment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Neoplasm Malignant | Phase 1 | Status: COMPLETED